第一单位：
Department of Pharmacology and Toxicology, University of Toronto, Medical Science Building, Room 4211, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
作者：
David F,Bodenstein [1]
;
Gabriel,Siebiger [2]
;
Yimu,Zhao [3]
;
Aaron J,Clasky [4]
;
Avinash N,Mukkala [5]
;
Erika L,Beroncal [1]
;
Lauren,Banh [6]
;
Lili,Aslostovar [7]
;
Sonya,Brijbassi [8]
;
Sarah E,Hogan [9]
;
James D,McCully [10]
;
Mohadeseh,Mehrabian [7]
;
Thomas H,Petersen [9]
;
Lisa A,Robinson [11]
;
Melanie,Walker [12]
;
Constantine,Zachos [8]
;
MITO2i-MbD Mitochondrial Transplant Consortium [13]
;
Sowmya,Viswanathan [14]
;
Frank X,Gu [15]
;
Ori D,Rotstein [16]
;
Marcelo,Cypel [17]
;
Milica,Radisic [18]
;
Ana C,Andreazza
作者单位：
Department of Pharmacology and Toxicology, University of Toronto, Medical Science Building, Room 4211, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[1]
Institute of Medical Science (IMS), University of Toronto, Toronto, Canada.;Latner Thoracic Research Laboratories, Toronto General Hospital, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[2]
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3G9, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[3]
Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[4]
Institute of Medical Science (IMS), University of Toronto, Toronto, Canada.;Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[5]
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3G9, Canada.;Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada.;Krembil Research Institute, University Health Network, Toronto, Canada.
[6]
Centre for Commercialization of Regenerative Medicine, Toronto, Canada.
[7]
Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[8]
Regenerative Medicine Department, United Therapeutics Corporation, Silver Spring, USA.
[9]
Harvard Medical School, Boston, USA.;Department of Cardiac Surgery, Boston Children's Hospital, Boston, USA.
[10]
Program in Cell Biology, The Hospital for Sick Children Research Institute, Toronto, Canada.
[11]
Department of Neurological Surgery, University of Washington, Seattle, USA.
[12]
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3G9, Canada.;Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.
[13]
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3G9, Canada.;Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.;Acceleration Consortium, University of Toronto, Toronto, ON, Canada.
[14]
Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.;Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Canada.;Department of Surgery, University of Toronto, Toronto, Canada.
[15]
Latner Thoracic Research Laboratories, Toronto General Hospital, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.;Toronto Lung Transplant Program, Division of Thoracic Surgery, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada.
[16]
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3G9, Canada.;Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Canada.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada.;Acceleration Consortium, University of Toronto, Toronto, ON, Canada.;Toronto General Hospital Research Institute, University Health Network, Toronto, ON, M5G 2C4, Canada.;Terence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, M5S 3E1, Canada.
[17]
Department of Pharmacology and Toxicology, University of Toronto, Medical Science Building, Room 4211, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. ana.andreazza@utoronto.ca.;Mitochondrial Innovation Initiative (MITO2i), Toronto, Canada. ana.andreazza@utoronto.ca.;Department of Psychiatry, University of Toronto, Toronto, ON, Canada. ana.andreazza@utoronto.ca.
[18]
DOI
10.1186/s13287-024-03771-8
PMID
38816774
发布时间
2025-07-07
换一批
